Tao Yuan

机构：University of Electronic Science and Technology of China, Army Medical University, Chinese University of Hong Kong, Daping Hospital, Zhejiang Lab, Jiangxi Normal University, Zhejiang University · ORCID：0000-0003-1624-6251

发表论文 97 篇 · 总被引 1647 次 · h-index 21

代表论文

• SDH defective cancers: molecular mechanisms and treatment strategies (2025 · Cell Biology and Toxicology · 被引 20)
• Josephin Domain Containing 2 (JOSD2) inhibition as Pan-KRAS-mutation-targeting strategy for colorectal cancer (2025 · Nature Communications · 被引 14)
• PTPN2: Advances and perspectives in cancer treatment potential and inhibitor research (2025 · International Journal of Biological Macromolecules · 被引 7)
• The role of calcium signaling in organotropic metastasis of cancer (2025 · Acta Pharmacologica Sinica · 被引 7)
• PD-1 inhibition disrupts collagen homeostasis and aggravates cardiac dysfunction through endothelial-fibroblast crosstalk and EndMT (2025 · Frontiers in Pharmacology · 被引 5)
• LncRNA NAV2-AS2 is critical for fibroblast-to-myofibroblast transition and cardiac fibrosis (2025 · International Journal of Biological Macromolecules · 被引 5)